EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Investigation of Phytochemicals From Clinically Tested Herbal Extracts as Potential Dihydrofolate Reductase Inhibitors for Buruli Ulcer

Alkhair Adam Khalil Mohamed iD, Tamekloe Woasiedem iD, Philip Collins Appiah-Ofori iD, Esraa Mohammed Abdulmahmoud Adam iD, Samuel Asiamah Obiri iD, Lawrence Sheringham Borquaye iD, Christian K Adokoh iD, Ghazi Elamin iD, Isaac Asiamah iD

BioMed Research International · 2025

DOI: 10.1155/bmri/4196295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, 2025. Verfasst von Alkhair Adam Khalil Mohamed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Allied Health Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Gha…. Hauptthemen laut MEDLINE: Phytochemicals, Tetrahydrofolate Dehydrogenase, Folic Acid Antagonists, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Buruli ulcer (BU), a neglected tropical disease caused by Mycobacterium ulcerans , requires more effective and accessible treatments. Clinical trials have shown the efficacy of herbal formulations containing Nicotiana tabacum , Mangifera indica , Carica papaya , and Solanum rugosum , although the active phytochemicals remain unstudied. In the present study, we employed an in silico approach to identify the active phytochemicals from these plants that could inhibit M. ulcerans dihydrofolate reductase ( Mu DHFR), a crucial enzyme for mycobacterial survival. A library of 172 phytochemicals was screened using molecular docking, followed by 300‐ns molecular dynamics (MD) simulations using AMBER for the top hits and standard drugs (methotrexate and trimethoprim). Binding free energies were calculated using the molecular mechanics/generalized born surface area (MM/GBSA) method. The extended MD simulations and post hoc MM/GBSA analysis revealed that kaempferol‐3‐O‐rutinoside ( Δ G bind −51.62 kcal/mol) and neochlorogenic acid ( Δ G bind −49.44 kcal/mol) exhibited the strongest and most stable binding to Mu DHFR. The binding energies were more favorable than both methotrexate ( Δ G bind −44.18 kcal/mol) and trimethoprim ( Δ G bind −41.01 kcal/mol) used as positive controls. Stability analyses (RMSD and RMSF) and principal component analysis (PCA) confirmed that these compounds form stable complexes and induce specific conformational states in the enzyme. Favorable ADMET profiles, particularly the lack of predicted skin sensitization, support their potential for topical use. This study identifies kaempferol‐3‐O‐rutinoside and neochlorogenic acid as the most promising lead candidates for developing novel BU therapies, warranting their prioritization for experimental validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytochemicalsTetrahydrofolate DehydrogenaseFolic Acid AntagonistsPlant ExtractsBuruli UlcerMolecular Docking SimulationMolecular Dynamics SimulationHumansMycobacterium ulceransComputer Simulation

Stichwörter der Autor:innen

Buruli ulcerMD simulationsMangifera indicaMycobacterium ulceransNicotiana tabacumdihydrofolate reductase (DHFR)in silico drug discoverymolecular dockingphytochemicals

Substanzen

PhytochemicalsTetrahydrofolate DehydrogenaseFolic Acid AntagonistsPlant Extracts

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Allied Health Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana, ucc.edu.gh.
  • Department of Chemistry, School of Physical Sciences, College of Agriculture and Natural Sciences, University of Cape Coast, Cape Coast, Ghana, ucc.edu.gh.
  • Department of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, knust.edu.gh.
  • Central Laboratory, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, knust.edu.gh.
  • Department of Forensic Sciences, School of Biological Sciences, College of Agriculture and Natural Sciences University of Cape Coast, Cape Coast, Ghana.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Karary University, Khartoum, Sudan, karary.edu.sd.

ORCID-Profile: Alkhair Adam Khalil Mohamed, Tamekloe Woasiedem, Philip Collins Appiah-Ofori, Esraa Mohammed Abdulmahmoud Adam, Samuel Asiamah Obiri, Lawrence Sheringham Borquaye, Christian K Adokoh, Ghazi Elamin, Isaac Asiamah

Zitieren

APA

Mohamed, A. A. K., Woasiedem, T., Appiah-Ofori, P. C., Adam, E. M. A., Obiri, S. A., Borquaye, L. S., Adokoh, C. K., Elamin, G., & Asiamah, I. (2025). In Silico Investigation of Phytochemicals From Clinically Tested Herbal Extracts as Potential Dihydrofolate Reductase Inhibitors for Buruli Ulcer. BioMed Research International. https://doi.org/10.1155/bmri/4196295

Vancouver

Mohamed AAK, Woasiedem T, Appiah-Ofori PC, Adam EMA, Obiri SA, Borquaye LS, et al. In Silico Investigation of Phytochemicals From Clinically Tested Herbal Extracts as Potential Dihydrofolate Reductase Inhibitors for Buruli Ulcer. BioMed Research International. 2025. doi:10.1155/bmri/4196295

BibTeX
@article{Mohamed2025,
  author = {Mohamed, Alkhair Adam Khalil and Woasiedem, Tamekloe and Appiah-Ofori, Philip Collins and Adam, Esraa Mohammed Abdulmahmoud and Obiri, Samuel Asiamah and Borquaye, Lawrence Sheringham and Adokoh, Christian K and Elamin, Ghazi and Asiamah, Isaac},
  title = {In Silico Investigation of Phytochemicals From Clinically Tested Herbal Extracts as Potential Dihydrofolate Reductase Inhibitors for Buruli Ulcer},
  journal = {BioMed Research International},
  year = {2025},
  doi = {10.1155/bmri/4196295}
}
Kostenlos starten →